Survey on Aimovig for CADTH – part 2
CADTH (Canadian Agency for Drugs and Technology in Health) is currently evaluating the clinical value of Aimovig (erenumab) for the prevention of migraine. The input from patient groups is solicited. If you have tried Aimovig for migraine prevention, we need your input! This survey is…
What causes migraine? Scientific answers.
People with migraine often wonder what’s the cause of their disabling symptoms. The science of migraine has been progressing, thanks to the hard work of researchers all around the world. Dr Elizabeth Leroux recently gave a talk in Calgary about the last discoveries on migraine….
Global Patient Advocacy Committee
GPAC = Global Patient Advocacy Committee People working together to improve migraine care and understanding. GPAC is a group of physicians, patient advocates and representants from institutions, associations and industries related to the migraine field. Countries represented included Brazil, Japan, Spain, Italy, France, US,…
Join other people with migraine during a 2-hour focus group!
Did you ever look for something you wanted to know about migraine but just could not find it? Here is your opportunity to speak up! Migraine Canada! Join other people with migraine during a 2-hour focus group to share your comments on how you’d like…
You are invited to be part of a dynamic focus group, geared to improve the website of Migraine Canada!
Join other Migraine Warriors during a 2-hour focus group to share your comments on migraine websites. We believe that you, and all other Canadians, deserve an Association for migraine and headaches support. Our current website will be improved to fit your needs; are you interested…
- Board of Directors
- Course and Workshop
- Migraine and Science
- Migraine and Society
- Migraine or Headache?
- Other headaches
- Preventing attacks
- Stop the attack
- Top Ten Topics of the EHMTIC congress in Glasgow
- What about Lifestyle?
- Women and Children